BH
TAK icon

Burk Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Burk Holdings’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33K Hold
83
– – ﹤0.01% 552
2026
Q1 		$1.54K Buy
+83
New +$1.46K ﹤0.01% 550

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Burk Holdings's TAK Position: Q2 2026 in Review

Burk Holdings held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 83 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #552.

Burk Holdings first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.54K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Burk Holdings held 83 shares of Takeda Pharmaceutical worth $1.33K as of Q2 2026.
  • Burk Holdings left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Burk Holdings's portfolio in Q2 2026, its #552 holding.
  • Burk Holdings first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Burk Holdings's Takeda Pharmaceutical position peaked at $1.54K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Burk Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.